Talkspace Inc
TALK2.355USD
+0.045+1.95%
Market hours （ET）Quotes delayed by 15 min
395.30MMarket Cap
134.82P/E TTM
More Details of Talkspace Inc Company
Talkspace, Inc. is a behavioral healthcare company, which offers access to a fully credentialed network of licensed therapists, psychologists and psychiatrists. Through its platform, the Company provides psychotherapy and psychiatry services to individuals, enterprises and health plans through both business-to-business (B2B) and business-to-customer (B2C) channels. In psychotherapy or talk therapy, members work with a licensed therapist or counsellor to treat specific mental health conditions, such as depression or anxiety, trauma and other human challenges, including by developing positive thinking and coping skills. In psychotherapy, the Company offers text, audio and video-based psychotherapy from licensed therapists. In psychiatry, members receive personalized, care from a prescriber who specializes in mental healthcare and prescription management. The Company offers its members a robust ecosystem for end-to-end behavioral healthcare.
Company Info
Ticker SymbolTALK
Company nameTalkspace Inc
IPO dateJun 09, 2020
CEODr. Jon Roger Cohen, M.D.
Number of employees521
Security typeOrdinary Share
Fiscal year-endJun 09
Address622 Third Avenue
CityNEW YORK
Stock exchangeNASDAQ Capital Market Consolidated
CountryUnited States of America
Postal code10017
Phone12122847206
Websitehttps://www.talkspace.com/
Ticker SymbolTALK
IPO dateJun 09, 2020
CEODr. Jon Roger Cohen, M.D.
Company Executives
Name
Name/Position
Position
Shareholding
Change
Mr. Douglas L. (Doug) Braunstein, J.D.
Mr. Douglas L. (Doug) Braunstein, J.D.
Chairman of the Board
Chairman of the Board
3.91M
+0.15%
Ms. Madhu Pawar
Ms. Madhu Pawar
Independent Director
Independent Director
280.22K
+1.19%
Mr. Curtis A. Warfield, CPA
Mr. Curtis A. Warfield, CPA
Independent Director
Independent Director
152.47K
+6.45%
Ms. Liat Ben-Zur
Ms. Liat Ben-Zur
Independent Director
Independent Director
14.50K
-86.58%
Mr. Gil Margolin
Mr. Gil Margolin
Chief Technology Officer
Chief Technology Officer
3.52K
--
Ms. Jacqueline E. (Jackie) Yeaney
Ms. Jacqueline E. (Jackie) Yeaney
Independent Director
Independent Director
--
--
Mr. Michael E. Hansen
Mr. Michael E. Hansen
Independent Director
Independent Director
--
--
Ms. Swati Abbott
Ms. Swati Abbott
Independent Director
Independent Director
--
--
Mr. Ian Harris
Mr. Ian Harris
Chief Financial Officer
Chief Financial Officer
--
--
Mr. John C. Reilly, J.D.
Mr. John C. Reilly, J.D.
Chief Legal Officer and Corporate Secretary
Chief Legal Officer and Corporate Secretary
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Douglas L. (Doug) Braunstein, J.D.
Mr. Douglas L. (Doug) Braunstein, J.D.
Chairman of the Board
Chairman of the Board
3.91M
+0.15%
Ms. Madhu Pawar
Ms. Madhu Pawar
Independent Director
Independent Director
280.22K
+1.19%
Mr. Curtis A. Warfield, CPA
Mr. Curtis A. Warfield, CPA
Independent Director
Independent Director
152.47K
+6.45%
Ms. Liat Ben-Zur
Ms. Liat Ben-Zur
Independent Director
Independent Director
14.50K
-86.58%
Mr. Gil Margolin
Mr. Gil Margolin
Chief Technology Officer
Chief Technology Officer
3.52K
--
Ms. Jacqueline E. (Jackie) Yeaney
Ms. Jacqueline E. (Jackie) Yeaney
Independent Director
Independent Director
--
--
Revenue Breakdown
Currency: USDUpdated: Sun, Jul 6
Currency: USDUpdated: Sun, Jul 6
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
By BusinessUSD
Name
Revenue
Proportion
Payor revenue
37.84M
72.52%
DTE revenue
9.58M
18.36%
Consumers
4.76M
9.12%
By RegionUSD
Name
Revenue
Proportion
United States
52.18M
100.00%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Payor revenue
37.84M
72.52%
DTE revenue
9.58M
18.36%
Consumers
4.76M
9.12%
Shareholding Stats
Updated: Sat, May 17
Updated: Sat, May 17
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Hudson Executive Capital LP
6.78%
Norwest Venture Partners
5.86%
The Vanguard Group, Inc.
5.36%
Qumra Capital
5.12%
BlackRock Institutional Trust Company, N.A.
4.63%
Other
72.25%
Shareholders
Shareholders
Proportion
Hudson Executive Capital LP
6.78%
Norwest Venture Partners
5.86%
The Vanguard Group, Inc.
5.36%
Qumra Capital
5.12%
BlackRock Institutional Trust Company, N.A.
4.63%
Other
72.25%
Shareholder Types
Shareholders
Proportion
Investment Advisor
16.73%
Investment Advisor/Hedge Fund
15.36%
Hedge Fund
13.17%
Venture Capital
11.00%
Individual Investor
3.94%
Research Firm
1.97%
Bank and Trust
0.07%
Pension Fund
0.04%
Family Office
0.02%
Other
37.68%
Institutional Shareholding
Updated: Tue, Jul 1
Updated: Tue, Jul 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q2
292
104.31M
62.34%
-39.59M
2025Q1
296
102.35M
61.03%
-39.58M
2024Q4
272
107.12M
63.41%
-30.51M
2024Q3
247
121.91M
72.97%
-25.59M
2024Q2
229
128.58M
76.43%
-10.36M
2024Q1
201
122.89M
73.40%
-12.38M
2023Q4
177
114.14M
68.86%
-16.32M
2023Q3
187
110.17M
66.67%
-25.83M
2023Q2
189
108.64M
66.92%
-30.95M
2023Q1
232
106.32M
65.93%
-50.16M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Hudson Executive Capital LP
11.34M
6.78%
--
--
Apr 21, 2025
Norwest Venture Partners
9.80M
5.86%
-4.90M
-33.33%
Mar 31, 2025
The Vanguard Group, Inc.
7.65M
4.57%
+469.54K
+6.54%
Mar 31, 2025
Qumra Capital
8.57M
5.12%
--
--
Apr 21, 2025
BlackRock Institutional Trust Company, N.A.
7.74M
4.63%
+62.46K
+0.81%
Mar 31, 2025
American Century Investment Management, Inc.
6.45M
3.85%
-565.60K
-8.06%
Mar 31, 2025
DWS Investment Management Americas, Inc.
5.00M
2.99%
+500.00K
+11.10%
Mar 31, 2025
AWM Investment Company, Inc.
3.97M
2.37%
+150.00K
+3.93%
Mar 31, 2025
Braunstein (Douglas L)
3.91M
2.33%
+5.76K
+0.15%
Jun 01, 2025
Geode Capital Management, L.L.C.
3.15M
1.88%
+69.31K
+2.25%
Mar 31, 2025
View more
Related ETFs
Updated: Sat, Aug 2
Updated: Sat, Aug 2
Name
Proportion
Tema Neuroscience and Mental Health ETF
0.92%
Fidelity Digital Health ETF
0.74%
SPDR S&P Health Care Services ETF
0.6%
SPDR S&P Kensho New Economies Composite ETF
0.18%
iShares Micro-Cap ETF
0.08%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.07%
WisdomTree US SmallCap Quality Growth Fund
0.07%
Principal U.S. Small-Cap ETF
0.05%
WisdomTree US SmallCap Fund
0.03%
Avantis US Small Cap Equity ETF
0.02%
View more
Tema Neuroscience and Mental Health ETF
Proportion0.92%
Fidelity Digital Health ETF
Proportion0.74%
SPDR S&P Health Care Services ETF
Proportion0.6%
SPDR S&P Kensho New Economies Composite ETF
Proportion0.18%
iShares Micro-Cap ETF
Proportion0.08%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
Proportion0.07%
WisdomTree US SmallCap Quality Growth Fund
Proportion0.07%
Principal U.S. Small-Cap ETF
Proportion0.05%
WisdomTree US SmallCap Fund
Proportion0.03%
Avantis US Small Cap Equity ETF
Proportion0.02%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
